Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about GRIN2B: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
GRIN2B is a gene implicated in neurodegeneration research. Key relationships include: associated with, implicated in, co discussed. Associated with ALS, Als, Alzheimer. Connected to 70 entities in the SciDEX knowledge graph.
No AI portrait yet
| Gene Symbol | GRIN2B |
| Full Name | NMDA Receptor Subunit 2B |
| Protein Type | Gene |
| Function | The GRIN2B subunit contributes to the unique pharmacological and biophysical properties of NMDA receptors |
| Primary Expression | Prefrontal Cortex, Cortex, Ventral Tegmental Area, Substantia Nigra |
| Pathways | Circadian Rhythm, Calcium Signaling, Epigenetic, synaptic plasticity |
| GeneCards | GRIN2B |
| Human Protein Atlas | GRIN2B |
| Calcium Permeability | NMDA receptors containing GRIN2B have high calcium permeability, enabling calcium-dependent signaling cascades essential for synaptic plasticity[@paoletti2013] |
| Slower Kinetics | GRIN2B-containing receptors have slower deactivation kinetics compared to GRIN2A-containing receptors |
| Developmental Regulation | GRIN2B expression peaks early in development and decreases with age as GRIN2A expression increases |
| Synaptic Localization | GRIN2B is primarily found at extrasynaptic and immature synapses |
| Synaptic Dysfunction | Aβ oligomers directly interact with NMDA receptors, causing internalization and impairment of glutamatergic signaling[@liu2021] |
| Excitotoxicity | Overactivation of NMDA receptors contributes to dopaminergic neuron death |
| Memory Deficits | NMDA receptor hypofunction, particularly involving GRIN2B, correlates with cognitive deficits in AD |
| Associated Diseases | Als, Alzheimer, Bipolar, Bipolar Disorder, Depression |
| Interactions | Albumin, DAO, DISC1, G72, GRM3, GRM4 |
| SciDEX Hypotheses | GluN2B-Mediated Thalamocortical Control of Glympha Thalamocortical Synchrony Restoration via NMDA Mod Cortico-Striatal Synchrony Restoration via NMDA Mo (+6 more) |
| KG Connections | 196 knowledge graph edges |
| Databases | GeneCardsUniProtNCBI GeneHPASTRING |
Knowledge base pages for this entity
flowchart TD
GRIN2B["GRIN2B"] -->|"associated with"| Schizophrenia["Schizophrenia"]
GRIN2B["GRIN2B"] -->|"associated with"| Als["Als"]
GRIN2B["GRIN2B"] -->|"associated with"| Depression["Depression"]
GRIN2B["GRIN2B"] -->|"associated with"| Bipolar["Bipolar"]
GRIN2B["GRIN2B"] -->|"associated with"| Ms["Ms"]
GRIN2B["GRIN2B"] -->|"associated with"| Alzheimer["Alzheimer"]
GRIN2B["GRIN2B"] -->|"associated with"| Inflammation["Inflammation"]
GRIN2B["GRIN2B"] -->|"associated with"| ALS["ALS"]
DLG4["DLG4"] -->|"associated with"| GRIN2B["GRIN2B"]
GRIN2B["GRIN2B"] -->|"associated with"| DRD1["DRD1"]
GRIN2B["GRIN2B"] -->|"associated with"| TPH2["TPH2"]
GRIN2B["GRIN2B"] -->|"associated with"| GABRA5["GABRA5"]
style GRIN2B fill:#4a1a6b,stroke:#333,color:#e0e0e0
style Schizophrenia fill:#ef5350,stroke:#333,color:#e0e0e0
style Als fill:#ef5350,stroke:#333,color:#e0e0e0
style Depression fill:#ef5350,stroke:#333,color:#e0e0e0
style Bipolar fill:#ef5350,stroke:#333,color:#e0e0e0
style Ms fill:#ef5350,stroke:#333,color:#e0e0e0
style Alzheimer fill:#ef5350,stroke:#333,color:#e0e0e0
style Inflammation fill:#ef5350,stroke:#333,color:#e0e0e0
style ALS fill:#ef5350,stroke:#333,color:#e0e0e0
style DLG4 fill:#4a1a6b,stroke:#333,color:#e0e0e0
style DRD1 fill:#4a1a6b,stroke:#333,color:#e0e0e0
style TPH2 fill:#4a1a6b,stroke:#333,color:#e0e0e0
style GABRA5 fill:#4a1a6b,stroke:#333,color:#e0e0e0| Target | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:GRIN2B | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | provides_data_for | dataset | 1.00 |
| thalamocortical_synchrony | modulates | pathway | 0.75 |
| MAPT | regulates | gene | 0.70 |
| PLP1 | regulates | gene | 0.70 |
| IDE | regulates | gene | 0.70 |
| PSEN2 | regulates | gene | 0.70 |
| SNAP25 | associated_with | gene | 0.70 |
| SYT1 | associated_with | gene | 0.70 |
| RELN | associated_with | gene | 0.70 |
| VAMP2 | associated_with | gene | 0.70 |
| SYN1 | associated_with | gene | 0.70 |
| IBA1 | regulates | gene | 0.70 |
| SQSTM1 | associated_with | gene | 0.70 |
| PSEN1 | associated_with | gene | 0.70 |
| Bipolar Disorder | associated_with | disease | 0.70 |
| ALS | associated_with | disease | 0.65 |
| ALS | activates | disease | 0.65 |
| Schizophrenia | expressed_in | disease | 0.65 |
| Inflammation | associated_with | disease | 0.65 |
| Alzheimer | associated_with | disease | 0.65 |
| Ms | associated_with | disease | 0.65 |
| Schizophrenia | associated_with | disease | 0.65 |
| Als | associated_with | disease | 0.65 |
| Depression | associated_with | disease | 0.65 |
| Bipolar | associated_with | disease | 0.65 |
| BMAL1 | associated_with | gene | 0.60 |
| Dopaminergic | activates | cell_type | 0.60 |
| NEURON | activates | cell_type | 0.60 |
| IGF1 | regulates | gene | 0.60 |
| DRD1 | associated_with | gene | 0.60 |
| TPH2 | associated_with | gene | 0.60 |
| GABRA5 | associated_with | gene | 0.60 |
| POLG | associated_with | gene | 0.60 |
| TRPM2 | associated_with | gene | 0.60 |
| GRM3 | associated_with | gene | 0.60 |
| GNA13 | associated_with | gene | 0.60 |
| GNAI1 | associated_with | gene | 0.60 |
| GNA12 | associated_with | gene | 0.60 |
| Circadian Rhythm | associated_with | pathway | 0.60 |
| Calcium Signaling | associated_with | pathway | 0.60 |
| PDLIM5 | associated_with | gene | 0.60 |
| MTDNA | associated_with | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| NCAM1 | interacts_with | gene | 0.60 |
| NRG1 | interacts_with | gene | 0.60 |
| RGS4 | interacts_with | gene | 0.60 |
| SYNGR1 | interacts_with | gene | 0.60 |
| GRM3 | interacts_with | gene | 0.60 |
| GRM4 | interacts_with | gene | 0.60 |
| Source | Relation | Type | Str |
|---|---|---|---|
| benchmark_ot_ad_answer_key:GRIN2B | data_in | dataset_row | 0.00 |
| ds-83b31ef18d49 | data_in | dataset | 1.00 |
| h-var-e2b5a7e7db | targets_gene | hypothesis | 0.90 |
| h-cd60e2ec | targets | hypothesis | 0.90 |
| h-var-5e33600319 | targets_gene | hypothesis | 0.90 |
| GRIN1 | expresses | gene | 0.70 |
| DYRK1A | associated_with | gene | 0.70 |
| GRIN1 | regulates | gene | 0.70 |
| APP | regulates | gene | 0.70 |
| GFAP | regulates | gene | 0.70 |
| ATG7 | regulates | gene | 0.70 |
| AIF1 | regulates | gene | 0.70 |
| DLG4 | associated_with | gene | 0.65 |
| PDLIM5 | associated_with | gene | 0.60 |
| GENES | expressed_in | gene | 0.60 |
| AD | regulates | gene | 0.60 |
| AUTOPHAGY | regulates | pathway | 0.60 |
| AΒ | regulates | gene | 0.60 |
| AD | associated_with | gene | 0.60 |
| DLG4 | regulates | gene | 0.60 |
| DNA | associated_with | gene | 0.60 |
| DEPRESSION | associated_with | gene | 0.60 |
| GLUTAMATERGIC | associated_with | cell_type | 0.60 |
| GRIN2A | causes | gene | 0.60 |
| GRIN1 | associated_with | gene | 0.60 |
| GRIN2A | associated_with | gene | 0.60 |
| SLC17A7 | expressed_in | gene | 0.60 |
| NR2B | regulates | gene | 0.60 |
| PSD95 | regulates | gene | 0.60 |
| FOS | regulates | gene | 0.60 |
| NPAS4 | regulates | gene | 0.60 |
| AD | co_discussed | gene | 0.60 |
| GRID1 | expressed_in | gene | 0.60 |
| DAO | interacts_with | gene | 0.60 |
| SYNGR1 | associated_with | gene | 0.60 |
| BDNF | associated_with | gene | 0.60 |
| BIPOLAR | associated_with | disease | 0.60 |
| GENES | regulates | gene | 0.60 |
| C-FOS | regulates | gene | 0.60 |
| G72 | interacts_with | gene | 0.60 |
| NCAM1 | associated_with | gene | 0.60 |
| RGS4 | associated_with | gene | 0.60 |
| CALB1 | associated_with | gene | 0.60 |
| KCNN3 | associated_with | gene | 0.60 |
| TRPM2 | associated_with | gene | 0.60 |
| DRD1 | associated_with | gene | 0.60 |
| GABRA5 | associated_with | gene | 0.60 |
| GRM3 | associated_with | gene | 0.60 |
| TPH2 | associated_with | gene | 0.60 |
| POLG | associated_with | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
Scientific analyses that reference this entity
neurodegeneration | 2026-04-04 | 9 hypotheses Top: 0.779
neuroscience | 2026-04-03 | 70 hypotheses Top: 0.964
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| No experiments found | |||||||
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| Inspired by molecular dynamic simulation, exploring chemical constituents of alc [PMID:40166865] | Shinge J, Muthal A, Walhekar V, Bagul C, | Journal of biomolecular struct | 2026 | 0 |
| Cognitive loss after brain trauma results from sex-specific activation of synapt [PMID:40796363] | Arizanovska D, Bush GF, Dallera CA, Folo | Brain | 2026 | 0 |
| Inhibition of GluN2B-containing N-methyl-D-aspartate receptors by radiprodil. [PMID:40994429] | Banke TG, Regan MC, Perszyk RE, Zhang L, | Brain | 2026 | 0 |
| GluN2B-specific NMDAR positive allosteric modulation reverses cognitive and beha [PMID:41512078] | Ge Y, Tian T, Li B, Axerio-Cillies P, Ch | Sci Adv | 2026 | 0 |
| Zipper-interacting Protein Kinase Modulates Gene Expression Linked to Synaptic a [PMID:41526727] | Mei Y, Zheng L, He M, Wang L, Zhou Y et | Mol Neurobiol | 2026 | 0 |
| Multi-biofluid metabolomics coupled with gene network reveals stage-specific alt [PMID:41534821] | Cadaxo AS, Cotrin JC, Valente AP, Lopes | Brain Res | 2026 | 0 |
| Aberrant mRNA splicing and impaired hippocampal neurogenesis in Grin2b mutant mi [PMID:41675057] | Farsi Z, Nicolella A, Simmons SK, Shin W | iScience | 2026 | 0 |
| From synapse to system: mechanistic pathways of neural signaling dysfunction in [PMID:41799440] | Gupta R, Jha NK, Kumar N, Nagraik R, Rav | Front Cell Dev Biol | 2026 | 0 |
| Multisession epidural direct current stimulation of the auditory cortex mitigate [PMID:41747412] | Fernández Del Campo IS, Cebrián-León A, | Hearing research | 2026 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Enhancing TREM2 expression activates microglia and modestly mitigates tau pathol [PMID:40122810] | ["Chen Kai", "Li Fuyao", "Zhang Shuwen", | Journal of neuroinflammation | 2025 | 0 |
| Neuropathology of incidental Lewy body & prodromal Parkinson's disease. [PMID:37173733] | Koeglsperger T, Rumpf SL, Schließer P, S | Molecular neurodegeneration | 2023 | 0 |
| Differential vulnerability of hippocampal CA3-CA1 synapses to Aβ. [PMID:35379353] | Unknown | Acta Neuropathol Commun | 2022 | 0 |
| Oxidized phosphatidylcholines found in multiple sclerosis lesions mediate neurod [PMID:33603230] | Dong Y, D'Mello C, Pinsky W, Lozinski BM | Nature neuroscience | 2021 | 0 |
| Tau accumulation triggers STAT1-dependent memory deficits by suppressing NMDA re [PMID:31085626] | Unknown | EMBO Rep | 2019 | 0 |
| Chronic brain inflammation causes a reduction in GluN2A and GluN2B subunits of N [PMID:24761931] | Unknown | Mol Brain | 2014 | 0 |
| Activation of NR1a/NR2B receptors by soluble factors from APP-stimulated monocyt [PMID:15212844] | Unknown | Neurobiol Aging | 2004 | 0 |
Multi-agent debates referencing this entity
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 6 · Score: 0.95 · 2026-04-27
closed · Rounds: 4 · Score: 0.65 · 2026-04-27
closed · Rounds: 4 · Score: 0.46 · 2026-04-27
closed · Rounds: 4 · Score: 0.71 · 2026-04-27
closed · Rounds: 4 · Score: 0.87 · 2026-04-27
closed · Rounds: 4 · Score: 0.48 · 2026-04-27
closed · Rounds: 4 · Score: 0.54 · 2026-04-27
closed · Rounds: 4 · Score: 0.19 · 2026-04-27
closed · Rounds: 4 · Score: 0.40 · 2026-04-27
Hypotheses and analyses mentioning GRIN2B in their description or question text
Score: 0.565 · neuroscience · 2026-04-20
## Mechanistic Overview Ketone-Primed Thalamocortical Enhancement of Glymphatic Tau Clearance starts from the claim that
Score: 0.491 · neuroscience · 2026-04-21
## Mechanistic Overview GluN2B-Regulated Microglial Phagocytosis of Tau Aggregates via CX3CR1 Signaling starts from the
Score: 0.485 · neuroscience · 2026-04-21
## Mechanistic Overview GluN2B-Mediated Perivascular Pericyte Control of Glymphatic Tau Clearance starts from the claim
Score: 0.380 · neuroscience · 2026-04-27
This hypothesis proposes that GluN2B-containing NMDA receptors on microglia directly regulate tau protein clearance thro